ABCC3
Basic information
Region (hg38): 17:50634777-50692253
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (168 variants)
- not_provided (21 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCC3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003786.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | |||||
missense | 157 | 16 | 176 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 157 | 25 | 4 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABCC3 | protein_coding | protein_coding | ENST00000285238 | 31 | 57476 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.21e-26 | 0.507 | 125260 | 0 | 488 | 125748 | 0.00194 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.630 | 848 | 901 | 0.941 | 0.0000552 | 9849 |
Missense in Polyphen | 288 | 321.22 | 0.89659 | 3591 | ||
Synonymous | 1.59 | 346 | 386 | 0.897 | 0.0000239 | 3216 |
Loss of Function | 2.29 | 52 | 73.1 | 0.711 | 0.00000358 | 799 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00378 | 0.00378 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.00174 | 0.00174 |
Finnish | 0.00116 | 0.00116 |
European (Non-Finnish) | 0.00210 | 0.00209 |
Middle Eastern | 0.00174 | 0.00174 |
South Asian | 0.00232 | 0.00229 |
Other | 0.00293 | 0.00294 |
dbNSFP
Source:
- Function
- FUNCTION: May act as an inducible transporter in the biliary and intestinal excretion of organic anions. Acts as an alternative route for the export of bile acids and glucuronides from cholestatic hepatocytes (By similarity). {ECO:0000250}.;
- Pathway
- Methotrexate Pathway, Pharmacokinetics;Bile secretion - Homo sapiens (human);ABC transporters - Homo sapiens (human);Codeine and Morphine Pathway, Pharmacokinetics;Fluoropyrimidine Pathway, Pharmacokinetics;Vinka Alkaloid Pathway, Pharmacokinetics;Lamivudine Pathway, Pharmacokinetics/Pharmacodynamics;Etoposide Pathway, Pharmacokinetics/Pharmacodynamics;Vincristine Action Pathway;Vinblastine Action Pathway;Vinorelbine Action Pathway;Vindesine Action Pathway;Etoposide Action Pathway;Lamivudine Metabolism Pathway;Etoposide Metabolism Pathway;Fluoropyrimidine Activity;Codeine and Morphine Metabolism;Drug Induction of Bile Acid Pathway;Constitutive Androstane Receptor Pathway;Pregnane X Receptor pathway;Nuclear Receptors Meta-Pathway;NRF2 pathway;Nuclear Receptors in Lipid Metabolism and Toxicity;Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling;Liver steatosis AOP;multi-drug resistance factors;Metabolism of lipids;Androgen and estrogen biosynthesis and metabolism;Metabolism;Recycling of bile acids and salts;Bile acid and bile salt metabolism;Transport of small molecules;Metabolism of steroids;Bile acid biosynthesis;ABC-family proteins mediated transport
(Consensus)
Recessive Scores
- pRec
- 0.279
Intolerance Scores
- loftool
- 0.0379
- rvis_EVS
- 0.69
- rvis_percentile_EVS
- 85.21
Haploinsufficiency Scores
- pHI
- 0.115
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.407
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.581
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Abcc3
- Phenotype
- homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- bile acid and bile salt transport;canalicular bile acid transport;transmembrane transport;ATP hydrolysis coupled anion transmembrane transport
- Cellular component
- vacuolar membrane;plasma membrane;integral component of plasma membrane;membrane
- Molecular function
- ATP binding;organic anion transmembrane transporter activity;bile acid-exporting ATPase activity;ATPase activity, coupled to transmembrane movement of substances;ATPase-coupled anion transmembrane transporter activity